Cargando…
DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism
One of the three most frequently documented copy number variations associated with autism spectrum disorder (ASD) is a 1q21.1 duplication that encompasses sequences encoding DUF1220 protein domains, the dosage of which we previously implicated in increased human brain size. Further, individuals with...
Autores principales: | Davis, Jonathan M., Searles, Veronica B., Anderson, Nathan, Keeney, Jonathon, Dumas, Laura, Sikela, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961203/ https://www.ncbi.nlm.nih.gov/pubmed/24651471 http://dx.doi.org/10.1371/journal.pgen.1004241 |
Ejemplares similares
-
The case for DUF1220 domain dosage as a primary contributor to anthropoid brain expansion
por: Keeney, Jonathon G., et al.
Publicado: (2014) -
Correction: DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism
Publicado: (2014) -
DUF1220 copy number is associated with schizophrenia risk and severity: implications for understanding autism and schizophrenia as related diseases
por: Searles Quick, V B, et al.
Publicado: (2015) -
Evolutionary History and Genome Organization of DUF1220 Protein Domains
por: O’Bleness, Majesta S., et al.
Publicado: (2012) -
Changing the name of the NBPF/DUF1220 domain to the Olduvai domain
por: Sikela, James M., et al.
Publicado: (2018)